Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: Call-2-Health: Preventing Type II Diabetes [NA]

View source ↗

Summary

The Call-2-Health trial, sponsored by Kaiser Permanente, to prevent Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED